Prognosis conferred by molecular features of appendix-derived Pseudomyxoma Peritonei
Introduction: Pseudomyxoma Peritonei (PMP) is an extremely rare disease characterized by progressive accumulation of mucinous ascites and implants in the peritoneum. We investigated the prognostic value for response to cytoreductive surgery (CRS) or hyperthermic intraperitoneal chemotherapy (HIPEC)...
Saved in:
| Main Authors: | Ruiqing Ma, Guojun Li, Yingjiang Ye, Lei Liang, Chong Wang, Haipeng Zhou, Pu Zhang, Lubiao An, Guanjun Shi, Qian Chen, Hongbin Xu, Zhidong Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325000105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Postoperative follow-up compliance and survival analysis in pseudomyxoma peritonei patients treated with CRS and HIPEC: a six-year retrospective study
by: Guang Yang, et al.
Published: (2024-11-01) -
Clinical features and prognostic analysis of 14 cases of appendiceal mixed neuroendocrine-non-neuroendocrine tumors with peritoneal pseudomyxoma
by: Pu Zhang, et al.
Published: (2025-05-01) -
Prophylactic oophorectomy is recommended in female patients with pseudomyxoma peritonei of an appendiceal origin
by: Fengxian Fu, et al.
Published: (2025-07-01) -
Pseudomyxoma peritonei: An uncommon tumor
by: Gupta Surabhi, et al.
Published: (2010-01-01) -
PSEUDOMYXOMA PERITONEI: A RARE ENTITY
by: Bahar Canbay Torun
Published: (2024-10-01)